Search for Stocks Search for IPO Search for Indices

Customer Portal

EMI Card

Download

Offers

BAJAJ FINSERV DIRECT LIMITED

Open Your FREE Demat Account Now!

Apply Now

Fundamentals Financials Shareholding About Company Peer Comparison Latest News FAQs

Shelter Pharma Ltd. Share Price

NSE

BSE

BSE : 543963

Sector : Healthcare

N/A

indicator

1D

1M

3M

6M

1Y

5Y

empty graph

Price Summary

Previous Close	₹31.60
Day's Range	₹31.60 - ₹33.00
Open	₹33.00
52 Week Range	₹23.00 - ₹46.98
Volume	21,000
Market Cap	₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs)	6.77
Market Cap (₹ in Mn)	0.00
Dividend Yield(%)	0.00
Price/Earning (TTM)	5.89
TTM EPS (₹)	5.36
P/E Ratio	5.78
Book Value(₹)	0.88
PAT Margin (%)	14.29
Face Value (₹)	10.00
ROCE(%)	25.07

Financials

Particulars	QTR FY (₹ in Millions)	Annual FY (₹ in Millions)
Net sales	N/A	506.6
Expenses	N/A	N/A
PBT	N/A	96.77
Operating profit	N/A	0.0
Net profit	N/A	72.37

Shareholding Pattern

Promoters (% Holding)

44.99%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

55.01%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Shelter Pharma Ltd.

Founded	2007
Managing Director	Mustaqim Nisarahmed Sabugar

Latest News

Aug

24

2026

EQUITY Posted on Aug 24^th 2026

Shelter Pharma informs about completion and commencement of dispatch of export order

Pursuant to Regulation 30 read with schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shelter Pharma has informed that the Company has successfully completed the manufacturing of the export purchase order received from Taha Drugs & Chemicals Co for the supply of Joemega Capsule aggregating 1,44,000 $. They further informed that the aforesaid amount has been fully settled and the said order has been dispatched to Sudan. The Management of Shelter Pharma has informed that the export order to Sudan has been successfully completed and delivered, thus setting yet another milestone in the growth journey of the Company. This success highlights the growing international presence of the Company along with its dedication towards prompt delivery of high-quality products to its customers around the globe. This success is a clear reflection of the modern manufacturing facility, stringent quality control systems and hard work of the team of experts at the Company. The success of the order once again highlights the commitment of the Company towards ethical business practices as well as the trust reposed in the Company by international stakeholders. As a growing name in the field of Pharmaceutical and Nutraceuticals, the Company continues to be committed towards innovation and quality in all its products.

The above information is a part of company’s filings submitted to BSE.

Read More

Jul

31

2026

EQUITY Posted on Jul 31^st 2026

Shelter Pharma informs about outcome of board meeting

Shelter Pharma has informed that Board of Directors of the Company at its meeting held today, Friday, 31st July, 2026 has discussed, approved, and taken on record the following matters attached.

The above information is a part of company’s filings submitted to BSE.

Read More

Jul

31

2026

EQUITY Posted on Jul 31^st 2026

Shelter Pharma informs about appointment of director

Shelter Pharma has informed that Board of Directors of the Company at its meeting held today, Friday, 31st July, 2026 approved appointment of Vinita Shivraj Gadhvi as an Additional Independent Director pursuant to the provisions of Sections 149, 152, and 161(1) read with Schedule IV of the Companies Act, 2013, and based on the recommendation of the Nomination and Remuneration Committee. Her tenure is fixed for a period of five consecutive years with effect from 31st July, 2026, subject to the approval of the shareholders of the Company during which she will not be liable to retire by rotation. The aforesaid Director are not related to any Director or Key Managerial Personnel on the Board of the Company. Further the Director is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority.

The above information is a part of company’s filings submitted to BSE.

Read More

Jul

27

2026

EQUITY Posted on Jul 27^th 2026

Shelter Pharma informs about award of order

Shelter Pharma has informed that the Company has received order from Genet International in the normal course of business. The aforesaid export orders represent a significant milestone in the Company's growth trajectory and reflect the company’s growing presence in international markets. The execution of these orders is expected to further strengthen the Company's global presence, enhance its export business, and contribute positively to its revenue growth and overall business expansion.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

4

2026

EQUITY Posted on Sep 4^th 2026

Asston Pharmaceuticals informs about SAST updates

Asston Pharmaceuticals has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali.

The above information is a part of company’s filings submitted to BSE.

Read More

Sign in to Unlock Offers!

STEP 1/2

Open Demat Account today!

Mobile Number

Enter mobile number

Frequently Asked Questions

What is the current share price of Shelter Pharma Ltd. ?

The current share price of Shelter Pharma Ltd. is ₹31.60 as of 2026-09-04.

What is the Market Cap of Shelter Pharma Ltd. Share?

The market capitalisation of Shelter Pharma Ltd. is ₹53.20 as of 2026-09-04.

What is a 1 year return for Shelter Pharma Ltd. ?

The 1-year return of Shelter Pharma Ltd. is -12.91% as of 2026-09-04.

What is the P/E Ratio of Shelter Pharma Ltd. Share?

The P/E ratio of Shelter Pharma Ltd. is 5.78 as of 2026-09-05.

What is the 52 Week High and Low of Shelter Pharma Ltd. ?

The 52-week high and low of Shelter Pharma Ltd. are ₹46.98 and ₹23.00, respectively, as of 2026-09-04.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.

STEP 1/2

Open a Demat Account today!

Mobile Number Enter Valid Mobile Number

Indices : Nifty 50 Nifty Bank Nifty Financial Services Nifty Next 50 Nifty Midcap 100 BSE Sensex India Vix

Stocks : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Home

Shopping

Loan Offers

My Accounts

Explore